DK1406642T3 - Fremgangsmåde til polyvalent bakteriofag-fremstilling til behandling af bakterielle infektioner - Google Patents

Fremgangsmåde til polyvalent bakteriofag-fremstilling til behandling af bakterielle infektioner

Info

Publication number
DK1406642T3
DK1406642T3 DK02751919T DK02751919T DK1406642T3 DK 1406642 T3 DK1406642 T3 DK 1406642T3 DK 02751919 T DK02751919 T DK 02751919T DK 02751919 T DK02751919 T DK 02751919T DK 1406642 T3 DK1406642 T3 DK 1406642T3
Authority
DK
Denmark
Prior art keywords
treatment
bacterial infections
bacteriophage preparation
polyvalent bacteriophage
polyvalent
Prior art date
Application number
DK02751919T
Other languages
English (en)
Inventor
Beata Weber-Dabrowska
Marian Mulczyk
Andrzej Gorski
Janusz Boratynski
Marzanna Lusiak-Szelachowska
Danuta Syper
Original Assignee
Inst Immunologii I Terapii Dos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PL348740A external-priority patent/PL195437B1/pl
Priority claimed from PL02354822A external-priority patent/PL354822A1/xx
Application filed by Inst Immunologii I Terapii Dos filed Critical Inst Immunologii I Terapii Dos
Application granted granted Critical
Publication of DK1406642T3 publication Critical patent/DK1406642T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/00032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK02751919T 2001-07-18 2002-07-18 Fremgangsmåde til polyvalent bakteriofag-fremstilling til behandling af bakterielle infektioner DK1406642T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PL348740A PL195437B1 (pl) 2001-07-18 2001-07-18 Sposób przygotowania poliwalentnych preparatów fagowych do leczenia zakażeń bakteryjnych
PL02354822A PL354822A1 (en) 2002-06-30 2002-06-30 Method of receiving purified bacteriophage preparations and new applications of polysaccharide or its esterificated derivative
PCT/PL2002/000053 WO2003008564A2 (en) 2001-07-18 2002-07-18 Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections

Publications (1)

Publication Number Publication Date
DK1406642T3 true DK1406642T3 (da) 2007-07-02

Family

ID=26653403

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02751919T DK1406642T3 (da) 2001-07-18 2002-07-18 Fremgangsmåde til polyvalent bakteriofag-fremstilling til behandling af bakterielle infektioner

Country Status (12)

Country Link
US (1) US7232564B2 (da)
EP (1) EP1406642B1 (da)
JP (1) JP4723807B2 (da)
KR (1) KR100874888B1 (da)
CN (1) CN1260353C (da)
AT (1) ATE355069T1 (da)
AU (1) AU2002354900A1 (da)
DE (1) DE60218473T2 (da)
DK (1) DK1406642T3 (da)
EA (1) EA007472B1 (da)
ES (1) ES2283581T3 (da)
WO (1) WO2003008564A2 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL354822A1 (en) * 2002-06-30 2004-01-12 Instytut Immunologii i Terapii Doświadczalnej PANwe Wrocławiu Method of receiving purified bacteriophage preparations and new applications of polysaccharide or its esterificated derivative
ES2527994T3 (es) 2003-07-23 2015-02-03 Biocontrol Limited Agentes terapéuticos que contienen bacteriófagos frente a P. aeruginosa
WO2006092629A1 (en) * 2005-03-04 2006-09-08 Blaze Venture Technologies Limited Method and device for bacterial sampling
CN100413962C (zh) * 2005-06-16 2008-08-27 华中科技大学同济医学院附属同济医院 一种作用于产超广谱β-内酰胺酶大肠杆菌噬菌体
EP1907534B2 (en) * 2005-07-12 2024-04-10 Micreos B.V. Bacteriophage and their uses
US20070292397A1 (en) * 2006-06-19 2007-12-20 Mcnulty Amy K Method for the detection and neutralization of bacteria
GB0704553D0 (en) 2007-03-09 2007-04-18 Harper David R Beneficial effects of bacteriophage treatments
JP5720045B2 (ja) * 2008-12-26 2015-05-20 国立大学法人東京工業大学 スタフィロコッカス・アウレウス溶菌性バクテリオファージ
KR100935387B1 (ko) 2009-07-10 2010-01-06 주식회사 엘에스텍 레이저를 이용한 패턴형성장치
KR100952201B1 (ko) 2009-07-10 2010-04-09 주식회사 엘에스텍 레이저를 이용한 패턴형성장치
KR100952202B1 (ko) 2009-09-11 2010-04-09 주식회사 엘에스텍 도광판용 패턴형성장치
RU2474431C1 (ru) * 2011-08-09 2013-02-10 Татьяна Николаевна Зарипова Способ лечения острых и обострений хронического ларингита
CN103555673B (zh) * 2013-10-23 2016-01-20 靳静 体外筛选体内抗菌活性噬菌体的方法
RU2664681C1 (ru) * 2017-09-06 2018-08-21 Андрей Владимирович Алешкин Способ лечения инфекции, связанной с оказанием медицинской помощи, вызванной возбудителем или возбудителями с множественной лекарственной устойчивостью
KR102774411B1 (ko) * 2021-10-27 2025-02-27 전북대학교산학협력단 재증식 풀 컬쳐 기반 박테리오파지 스크리닝 방법

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB829266A (en) * 1957-03-20 1960-03-02 Biogena A method of manufacturing bacteriophages in solid dry form
SU543260A1 (ru) 1975-07-25 1984-04-15 Всесоюзный Ордена Трудового Красного Знамени Научно-Исследовательский Противочумный Институт "Микроб" Способ получени холерных бактериофагов дл дифференциации вибрионов Эль-Тор на вирулентные и авирулентные
CS192212B1 (en) 1977-04-22 1979-08-31 Miloslav Mazacek Method of producing dry form bacteriophages
US4118315A (en) * 1977-04-28 1978-10-03 Nasa Water system virus detection
US4797363A (en) * 1984-03-19 1989-01-10 Board Of Trustees, University Of Illinois Bacteriophages as recognition and identification agents
US4828999A (en) * 1986-07-21 1989-05-09 Jackson Le Roy E Bacteriophage prevention and control of harmful plant bacteria
EP0290295B1 (en) 1987-05-07 1992-08-05 Microbial Developments Limited Antimicrobial preparations
WO1990003122A1 (en) 1988-09-26 1990-04-05 Microbial Developments Limited Antimicrobial preparations
US5846604A (en) * 1988-03-14 1998-12-08 Nextec Applications, Inc. Controlling the porosity and permeation of a web
GB8918983D0 (en) 1989-08-21 1989-10-04 Unilever Plc Composition for hygiene purposes
DE4005874A1 (de) 1990-02-24 1991-11-07 Boehringer Mannheim Gmbh Traegergebundene rekombinante proteine, verfahren zur herstellung und verwendung als immunogene und vakzine
GB2253859A (en) 1991-02-28 1992-09-23 Microbial Dev Ltd Use of bacteriophages to prevent microbial infestation
GB2255561B (en) 1991-04-20 1995-06-21 Agricultural & Food Res Lysins from bacteriophages
WO1995005454A1 (en) 1992-02-22 1995-02-23 Cambridge Bacteriophage Technologies Ltd. Engineered bacteriophages and vaccines containing them
GB9220027D0 (en) 1992-09-22 1992-11-04 Mini Agriculture & Fisheries Method and kits for detection of bacteria
CA2199478A1 (en) 1994-09-09 1996-03-14 Allan L. Delisle Bacteriophage-encoded enzymes for the treatment and prevention of dental caries and periodontal diseases
GB9500851D0 (en) 1995-01-17 1995-03-08 Bionvent International Ab Method of selecting specific bacteriophages
DE19517940A1 (de) 1995-05-18 1996-11-21 Merck Patent Gmbh Nachweis von Listerien mittels rekombinanter Bakteriophagen
EP0895534A1 (en) * 1996-04-15 1999-02-10 Nymox Corporation Compositions containing bacteriophages and methods of using bacteriophages to treat infections
WO1998008944A1 (fr) 1996-08-26 1998-03-05 Bio Venture Bank Co., Ltd. Nouveau bacteriophage et procede de criblage associe, nouvelles matieres biobactericides preparees avec ledit bacteriophage et reactif utilise pour detecter celui-ci
US6322783B1 (en) 1996-08-26 2001-11-27 Seishi Takahashi Bacteriophages, method for screening same and bactericidal compositions using same, and detection kits using same
RU2109055C1 (ru) * 1996-11-27 1998-04-20 Дочернее предприятие "Биофаг" Научно-производственного объединения "Иммунопрепарат" Способ выделения бактериофагов
DE19828596A1 (de) * 1997-06-26 1999-02-11 A Daniela Dr Nodar Wirksames Arzneimittel gegen bakterielle Erkrankungen und Herstellung desselben
US6982153B1 (en) * 1998-12-03 2006-01-03 Targanta Therapeutics, Inc. DNA sequences from staphylococcus aureus bacteriophage 77 that encode anti-microbial polypeptides
US6245504B1 (en) * 1999-03-26 2001-06-12 The University Of Georgia Research Foundation, Inc. Transducing phages of Actinomycetales
US6482632B1 (en) * 1999-03-29 2002-11-19 Council Of Scientic And Industrial Research Bacteriophage, a process for the isolation thereof, and a universal growth medium useful in the process thereof
WO2000061804A1 (en) * 1999-04-14 2000-10-19 Musc Foundation For Research Development Tissue-specific and pathogen-specific toxic agents and ribozymes
AU5423400A (en) 1999-06-25 2001-01-31 Spring Diagnostics Ltd. Bacteriophage library useful for typing bacteria and system and method utilizingsame
DE50012134D1 (de) 1999-07-30 2006-04-13 Profos Ag Nachweis und identifikation von bakterienstämmen
CA2430501A1 (en) * 2000-01-11 2001-07-19 Intralytix, Inc. Method for produce sanitation using bacteriophages
ES2252263T3 (es) * 2000-07-25 2006-05-16 The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Bacteriofago que tiene una gama de hospedadores multiple.
US6461608B1 (en) * 2000-11-22 2002-10-08 Nymox Pharmaceutical Corporation Bacteriophage composition useful in treating food products to prevent bacterial contamination

Also Published As

Publication number Publication date
EA007472B1 (ru) 2006-10-27
AU2002354900A1 (en) 2003-03-03
CN1260353C (zh) 2006-06-21
WO2003008564A2 (en) 2003-01-30
DE60218473D1 (de) 2007-04-12
DE60218473T2 (de) 2007-11-08
US7232564B2 (en) 2007-06-19
WO2003008564A3 (en) 2003-11-06
JP4723807B2 (ja) 2011-07-13
KR20040029372A (ko) 2004-04-06
CN1541101A (zh) 2004-10-27
ES2283581T3 (es) 2007-11-01
EP1406642B1 (en) 2007-02-28
EA200400197A1 (ru) 2004-06-24
US20050032036A1 (en) 2005-02-10
JP2004535812A (ja) 2004-12-02
ATE355069T1 (de) 2006-03-15
KR100874888B1 (ko) 2008-12-19
EP1406642A2 (en) 2004-04-14

Similar Documents

Publication Publication Date Title
DK1406642T3 (da) Fremgangsmåde til polyvalent bakteriofag-fremstilling til behandling af bakterielle infektioner
ATE340171T1 (de) Piperazinderivate zur behandlung bakterieller infektionen
WO2007030810A3 (en) Multiparameter whole blood monitor and method
CY1112560T1 (el) Πνευμονικη μεταφορα των αμινογλυκοσιδων
WO2004069156A3 (en) Inactivated probiotic bacteria and methods of use thereof
DE60113851D1 (de) Bakteriophage mit breitem wirtspektrum
MXPA02012819A (es) Dispositivo y metodo para tratamiento intravaginal o transvaginal de infecciones fungales, bacterianas, virales o parasitarias.
ATE344799T1 (de) Piperidinderivate als antibakterielle mittel
CY1107451T1 (el) Υδροβρωμικον escitalopram και μεθοδος δια την παρασκευη αυτου
NO20050427L (no) Carvedilolfosfatsalter og/eller solvater derav, tilsvarende preparater og/eller behandlingsfremgangsmater
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
NL1024676A1 (nl) HIV integrase-remmers, farmaceutische preparaten en methoden voor het gebruik daarvan.
EP1917355A4 (en) PLY-GBS MUTANT LYSINE
ITRM20040586A1 (it) Epitopi antigenici dell'interleuchina-21, anticorpi relativi e loro uso in campo medico.
DK1163231T3 (da) Perfluoralkylamider, deres fremstilling og deres anvendelse inden for diagnostikken
WO2001040473A3 (en) Pseudomonas aeruginosa antigens
WO2005034857A8 (en) Methods and compositions comprising diamines as new anti-tubercular therapeutics
DK1406927T3 (da) Glycopeptider, fremstilling og anvendelse deraf til diagnosticering eller terapeutisk behandling af dissemineret sklerose
ATE433459T1 (de) Desoxo-nonadepsipeptide
BR0111785A (pt) Composições e métodos para tratamento de candidìase
NO20031108D0 (no) Farmasöytisk preparat for behandling av hodepine, og fremgangsmåte for fremstilling av preparatet
NO20062469L (no) Streptococcus phocae vaksine
DE502005008925D1 (de) Substituierte nonadepsipeptide
ATE313628T1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen